Tumor mutation burden trang 1 tải miễn phí từ TAILIEUCHUNG

"Tumor mutation burden" trang 1 - tải miễn phí từ Tailieuchung

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

13 33 1

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

12 24 1

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study

9 24 1

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

17 28 1

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

11 25 1

Gene expression and immune infiltration in melanoma patients with different mutation burden

Gene expression and immune infiltration in melanoma patients with different mutation burden

12 15 1

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

16 56 0

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

19 17 1

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

8 38 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.